As artificial intelligence becomes embedded in clinical workflows, trials must accommodate ongoing monitoring and updates.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Mark Sendak
Healthcare AI Companies are Building for the Wrong Buyers
Mark Sendak is the CEO of a healthcare AI company serving community hospitals. He is a founder of Health AI Partnership and formerly worked at the Duke Institute for Health Innovation for over a decade. The leader of a community hospital system in Kentucky recently told me, “I’ve exhausted our resources trying to keep up with AI”. Another leader in South Dakota wasn’t sold by the marketing of a well-known AI vendor.
Healthcare AI Adoption: Overcoming Barriers to Clinical Implementation - HIMSS 2026 Insights from Duke
Earlier this week, I had the privilege of moderating a fireside chat at the HIMSS AI Preconference Forum with two people who have shaped my career: Suresh Balu and Eric Poon. Suresh and Eric are former colleagues and mentors. Our relationship was forged over the 10 years the three of us spent together at Duke. That shared history gave our conversation in Las Vegas a depth that allowed us all to be candid about the issues health systems continue to face with innovation.
Building models, building capacity: A review of participatory machine learning for HIV prevention
Citation: Sendak M, Young M, Kim JY, Hasan A, Kelsey C, O’Neal C, et al. (2025) Building models, building capacity: A review of participatory machine learning for HIV prevention. PLOS Glob Public Health 5(6): e0003862. https://doi.org/10.1371/journal.pgph.0003862 Editor: Marie A. Brault, NYU Grossman School of Medicine: New York University School of Medicine, UNITED STATES OF AMERICA Published: June 4, 2025 Copyright: © 2025 Sendak et al.
Proactive Algorithm Monitoring to Ensure Health Equity
Health care organizations are grappling with how to discover and mitigate the risks of artificial intelligence (AI) and associated algorithms worsening racial, ethnic, and socioeconomic health disparities.
Enabling collaborative governance of medical AI - Nature Machine Intelligence
Medical artificial intelligence needs governance to ensure safety and effectiveness, not just centrally (for example, by the US Food and Drug Administration) but also locally to account for differences in care, patients and system performance. Practical collaborative governance will enable health systems to carry out these challenging governance tasks, supported by central regulators.
Unlocking the potential of qualitative research for the implementation of artificial intelligence-enabled healthcare
Editorial Unlocking the potential of qualitative research for the implementation of artificial intelligence-enabled healthcare Henry David Jeffry Hogg, Mark Philip Sendak, Alastair Keith Denniston, Pearse Andrew Keane, Gregory Maniatopoulos
What can AI do for health care? Possibilities and pitfalls in an increasingly digital world
Share: Elizabeth Kwo, M.D., M.B.A., M.P.H.Speaker Mark Sendak, M.D., M.P.P.Speaker Xiaoxuan Liu, MBChB, Ph.D.Speaker Sean Sanders, Ph.D.Moderator This webinar is brought to you by the Science/AAAS Custom Publishing Office. The term “artificial intelligence” is everywhere, but what does it mean and how can it affect us in a practical sense?
Increasing AI Tool Adoption by Front-Line Workers
Topics AI progress can stall when end users resist adoption. Developers must think beyond a project’s business benefits and ensure that end users’ workflow concerns are addressed. Some of the biggest challenges in AI implementation can arise when a tool is ready to roll out to end users — and those users resist adoption. That’s typically because the project’s business sponsors are not the people expected to use the tool — and they have failed to address the needs and priorities of end users.
AI on the Front Lines
Topics subscribe-icon Subscribe Buy Share The Analysis The authors observed the design, development, and integration of 15 AI decision support tools over the past five years at Duke Health. They gathered data on the challenges that AI tool implementation presented to hospital managers, end users, and tool developers, focusing on decision support tools in particular.
Funding Black and Latinx community institutions is the key to vaccine equity
When our team at Duke Health launched a bilingual COVID-19 symptom monitoring program last March, we noticed over 90 percent of participants enrolling were white. We quickly started collaborating with nonprofit design studio IDEO.org on the question: how can we design COVID-19 interventions that challenge systemic racism and prioritize care for the most vulnerable among us?
Funding Black and Latinx community institutions is the key to vaccine equity
When our team at Duke Health launched a bilingual COVID-19 symptom monitoring program last March, we noticed over 90 percent of participants enrolling were white. We quickly started collaborating with nonprofit design studio IDEO.org on the question: how can we design COVID-19 interventions that challenge systemic racism and prioritize care for the most vulnerable among us?
Accelerating Digital Health To Achieve Equitable Delivery Of The COVID-19 Vaccine
The COVID-19 pandemic has spurred a dramatic acceleration in digital health including telemedicine, remote monitoring for chronic conditions, and mobile apps for contact tracing, as well as school and small-business safety monitoring. Perhaps the best-known example is the use of telemedicine to facilitate safe and effective means of triaging and accessing COVID-19 testing—including for individuals who have traditionally been poorly served by the health system.
Bio Eats World: It's Time to Build in Healthcare—COVID 19, Innovation, and What Comes Next - Andreessen Horowitz
In this episode of Bio Eats World, a16z founder and internet pioneer Marc Andreessen and general partner Jorge Conde zoom out to discuss the large scale societal effects of the current pandemic on society, healthcare, biotech, and innovation. COVID-19 has been catastrophic—but also catalyzed enormous change and a dramatic groundswell of innovation. Which of these changes will stay, and which may recede?
Journal Club: Super-Scaling COVID-19 Testing with DNA Sequencing
There is a wide range of diagnostic tests for COVID-19 that are all well suited for determining whether an individual patient is sick with the virus. But to safely reopen society in the absence of a vaccine, we need tests that can be given broadly across a population, including to people who are asymptomatic. Many of these existing tests cannot be administered at this grand scale. That is where SwabSeq comes in.
Bio Eats World: Going Back to the Workplace in a Pandemic
It’s not normal to talk to your employer about the details of your health: your current temperature, who you’ve been exposed to, whether your kid is sick, whether or not you’ve been social distancing. So how do employers handle and manage this entirely new process of employees returning to the workplace in the midst of an ongoing pandemic?
Presenting machine learning model information to clinical end users with model facts labels
There is tremendous enthusiasm surrounding the potential for machine learning to improve medical prognosis and diagnosis. However, there are risks to translating a machine learning model into clinical care and clinical end users are often unaware of the potential harm to patients. This perspective presents the “Model Facts” label, a systematic effort to ensure that front-line clinicians actually know how, when, how not, and when not to incorporate model output into clinical decisions.
A Path for Translation of Machine Learning Products into Healthcare Delivery
INTRODUCTION Machine learning is a set of statistical and computational techniques that is becoming increasingly prominent in the lay press and medical research. Outside of healthcare, machine learning was quickly adopted to recommend movies and music, annotate images, and translate language. In healthcare, in which the stakes are high, although the enthusiasm surrounding machine learning is immense,1 the evidence of clinical impact remains scant.
Author Correction: Do no harm: a roadmap for responsible machine learning for health care
Access provided by Correction to: Nature Medicine https://doi.org/10.1038/s41591-019-0548-6, published online 19 August 2019. In the version of this article initially published, an affiliation was missing for author Anna Goldenberg: Child and Brain Development Program, CIFAR, Toronto, Ontario, Canada. The error has been corrected in the HTML and PDF versions of the article.
Do no harm: a roadmap for responsible machine learning for health care
Abstract Interest in machine-learning applications within medicine has been growing, but few studies have progressed to deployment in patient care. We present a framework, context and ultimately guidelines for accelerating the translation of machine-learning-based interventions in health care. To be successful, translation will require a team of engaged stakeholders and a systematic process from beginning (problem formulation) to end (widespread deployment).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Mark
Contact Mark, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack